Table 1. The clinical characteristics of AML samples in the training and test sets.
| Characteristic | Test set | Training set | P value | Adj P value |
|---|---|---|---|---|
| Age (year) | ||||
| ≤60 | 29 | 69 | <0.0001 | 0.00011 |
| >60 | 21 | 51 | 0.00041 | 0.00081 |
| Sex | ||||
| Female | 30 | 50 | 0.02535 | 0.05069 |
| Male | 20 | 70 | 0 | 0 |
| TMB | ||||
| High | 25 | 55 | <0.0001 | 0.00159 |
| Low | 25 | 65 | <0.0001 | <0.0001 |
| Group | ||||
| Test | 50 | 0 | 0 | 0 |
| Train | 0 | 120 | 0 | 0 |
AML, acute myeloid leukemia; TMB, tumor mutational burden.